Literature DB >> 30555571

Erratum: In-Tether Chiral Center Induced Helical Peptide Modulators Target p53-MDM2/MDMX and Inhibit Tumor Growth in Stem-Like Cancer Cell: Erratum.

Kuan Hu1, Feng Yin1, Mengyin Yu1, Chengjie Sun1, Jingxu Li1, Yujie Liang1, Wenjun Li1, Mingsheng Xie1, Yuanzhi Lao2, Wei Liang3, Zi-Gang Li1.   

Abstract

[This corrects the article DOI: 10.7150/thno.19840.].

Entities:  

Year:  2018        PMID: 30555571      PMCID: PMC6276290          DOI: 10.7150/thno.31152

Source DB:  PubMed          Journal:  Theranostics        ISSN: 1838-7640            Impact factor:   11.556


In our paper 1, Figure 3 should be corrected as follows.
Figure 3

(A, B) MeR/PhR stabilize p53 and elevate protein levels of p53 and its targets MDM2 and MDMX. Log-phase PA-1 and MCF-7 cells were incubated with 40 μM peptides (MeR/S, PhR/S) or 1 μM nutlin-3a, and cell lysates were analyzed by Western blotting. (C, D) PhR shows induction of p53 and p53 target genes in p53wt cell lines. Exponentially growing p53wt cancer cell lines were incubated with 40 μM peptides or 1 μM nutlin-3a for 48 h, and mRNA level of p53 and p53 targets MDM2, MDMX, and MIC or stemness-related genes were analyzed by quantitative PCR and expressed as fold increase. Error bars represent SEMs for triplicates of three independent experiments, **, P<0.01. *, P<0.05.

  1 in total

1.  In-Tether Chiral Center Induced Helical Peptide Modulators Target p53-MDM2/MDMX and Inhibit Tumor Growth in Stem-Like Cancer Cell.

Authors:  Kuan Hu; Feng Yin; Mengyin Yu; Chengjie Sun; Jingxu Li; Yujie Liang; Wenjun Li; Mingsheng Xie; Yuanzhi Lao; Wei Liang; Zi-Gang Li
Journal:  Theranostics       Date:  2017-10-13       Impact factor: 11.556

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.